Lithium-induced ADH resistance in toad urinary bladders.
D000584:Amiloride / Q000494:pharmacology; D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D002024:Bufo marinus; D002794:Choline / Q000494:pharmacology; D000242:Cyclic AMP / Q000494:pharmacology; D003919:Diabetes Insipidus / Q000139:chemically induced; D004347:Drug Interactions; D005260:Female; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D007674:Kidney Diseases / Q000139:chemically induced; D008094:Lithium / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D008274:Magnesium / Q000494:pharmacology; D008564:Membrane Potentials / Q000187:drug effects; D011188:Potassium / Q000494:pharmacology; D011422:Propionates / Q000494:pharmacology; D012964:Sodium / Q000494:pharmacology; D014223:Triamterene / Q000494:pharmacology; D001743:Urinary Bladder / Q000187:drug effects*; D014667:Vasopressins / Q000037:antagonists & inhibitors*
D011422:Propionates; D014667:Vasopressins; D000584:Amiloride; D008094:Lithium; D012964:Sodium; D000242:Cyclic AMP; D008274:Magnesium; D002794:Choline; D011188:Potassium; D014223:Triamterene